German Version

Fluvoxamine (E)-5-Methoxy-4'-(trifluormethyl)valerophenon-O-(2-aminoethyl)oxim, C18H21F3N2O2, M 318,35 g/mol

Selective Serotonin Reuptake Inhibitor (SSRI)

Trade Mark: Luvox®, Fevarin®



Treatment of depressions. In the USA, studies run for the treatment of children with fear conditions.


Do not use with MAO inhibitors, because of the danger of a Serotonine syndrome. Do not use at the same time with Tizanidin (Sirdalud)

Adverse Effects

Especially at the beginning, nausea, constipation, agitation and weight loss can occur. When setting off, reduce dose slowly, increased risk of suicides.


The determination of Fluvoxamine can take place after extraction by means of HPLC/DAD. Therapeutic levels: 0.15-0.25 µg/ml.

Custom Search




Last modification (M-D-Y): 02/08/2019 - IMPRINT - FAQ